ArticleJournal of magnetic resonance imaging : JMRI2026
Clustering of Cerebral Microbleeds in Cerebral Amyloid Angiopathy: A Flow Territory-Based Analysis.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCerebral microbleeds (CMBs) are a key imaging marker of cerebral amyloid angiopathy (CAA), but their individual spatial distribution and potential clustering remain poorly understood. PURPOSE: This study assessed whether CMBs exhibit patient-specific, flow territory-based clustering in sporadic (sCAA) and Dutch-type hereditary CAA (D-CAA). The arterial flow territory subdivision was chosen, considering the predilection of CMB location in the posterior cortex-not limited to the occipital lobe-and the prominent vascular role in CAA. STUDY TYPE: Retrospective cross-sectional study. POPULATION: Thirty-three participants (17 (52%) female, 65 ± 12 years old, 19 sCAA; 14 D-CAA) without symptomatic intracerebral hemorrhage (sICH) and ≥ 1 CMB were included for the main analysis. FIELD STRENGTH/SEQUENCE: 3 T MRI susceptibility-weighted imaging, multi-echo 3D gradient echo. ASSESSMENT: Spatial CMB patterns were evaluated by comparing observed versus expected CMB density within covariate-matched subgroups, accounting for age, sex, CAA-type, smoking, and hypertension. CMBs were manually annotated and assigned to six arterial flow territories (left/right ACA, MCA, PCA) using a standardized atlas. A sensitivity analysis was performed on all participants (including sICH+ participants). STATISTICAL TESTS: Expected values were calculated by multiplying flow territory CMB proportions per covariate-matched subgroup. Unweighted individual chi-square statistics were calculated, and statistical significance was assessed via permutation testing (10,000 replications) per covariate group.
resultsAcross covariate-matched subgroups, observed CMB counts significantly deviated from expected distributions, indicating substantial interindividual variability and within-participant clustering (χ DATA
conclusionThese findings indicate CMBs in CAA are not identically distributed but show patient-specific clustering within flow territories, suggesting variable regional vulnerability, potentially influenced by local pathology or vascular anatomy. EVIDENCE LEVEL: 1. TECHNICAL EFFICACY: Stage 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.